fadrozole has been researched along with Flushing in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnefoi, HR; Coombes, RC; da Luz, RJ; Dowsett, M; Houston, SJ; Powles, TJ; Rubens, RD; Smith, IE; Trunet, PF | 1 |
1 trial(s) available for fadrozole and Flushing
| Article | Year |
|---|---|
Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Confidence Intervals; Double-Blind Method; Fadrozole; Female; Flushing; Humans; Middle Aged; Nausea; Tamoxifen; Time Factors; Treatment Failure; Treatment Outcome | 1996 |